Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Inventory
Mizuho Medy Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Inventory
¥2.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Inventory
¥337.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Olympus Corp
TSE:7733
|
Inventory
¥215B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
Sysmex Corp
TSE:6869
|
Inventory
¥99.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Inventory
¥62B
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
JEOL Ltd
TSE:6951
|
Inventory
¥81.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Inventory?
Inventory
2.4B
JPY
Based on the financial report for Dec 31, 2025, Mizuho Medy Co Ltd's Inventory amounts to 2.4B JPY.
What is Mizuho Medy Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
11%
Over the last year, the Inventory growth was 17%. The average annual Inventory growth rates for Mizuho Medy Co Ltd have been 24% over the past three years , 11% over the past five years .
